NASDAQ:TIVC - Nasdaq - US8887053085 - Common Stock - Currency: USD
4.3
-0.06 (-1.38%)
The current stock price of TIVC is 4.3 USD. In the past month the price increased by 19.11%. In the past year, price decreased by -49.92%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.02 | 232.31B | ||
ISRG | INTUITIVE SURGICAL INC | 70.18 | 192.17B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.81 | 155.01B | ||
SYK | STRYKER CORP | 30.65 | 146.59B | ||
MDT | MEDTRONIC PLC | 15.57 | 106.66B | ||
BDX | BECTON DICKINSON AND CO | 11.86 | 47.99B | ||
EW | EDWARDS LIFESCIENCES CORP | 28.86 | 44.12B | ||
IDXX | IDEXX LABORATORIES INC | 42.69 | 39.43B | ||
RMD | RESMED INC | 26.95 | 35.88B | ||
DXCM | DEXCOM INC | 50.52 | 32.68B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 14.96 | 31.51B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 15.51 | 22.46B |
Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company is headquartered in Fremont, California and currently employs 7 full-time employees. The company went IPO on 2021-11-11. The company harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. The company takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. The company also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.
TIVIC HEALTH SYSTEMS INC
47685 Lakeview Blvd
Fremont CALIFORNIA US
Employees: 7
Phone: 18882766888
The current stock price of TIVC is 4.3 USD. The price decreased by -1.38% in the last trading session.
The exchange symbol of TIVIC HEALTH SYSTEMS INC is TIVC and it is listed on the Nasdaq exchange.
TIVC stock is listed on the Nasdaq exchange.
TIVIC HEALTH SYSTEMS INC (TIVC) has a market capitalization of 2.92M USD. This makes TIVC a Nano Cap stock.
TIVIC HEALTH SYSTEMS INC (TIVC) currently has 7 employees.
TIVIC HEALTH SYSTEMS INC (TIVC) has a support level at 4.29. Check the full technical report for a detailed analysis of TIVC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TIVC does not pay a dividend.
TIVIC HEALTH SYSTEMS INC (TIVC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-19.68).
The outstanding short interest for TIVIC HEALTH SYSTEMS INC (TIVC) is 7.99% of its float. Check the ownership tab for more information on the TIVC short interest.
ChartMill assigns a technical rating of 1 / 10 to TIVC. When comparing the yearly performance of all stocks, TIVC is a bad performer in the overall market: 79.03% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to TIVC. While TIVC has a great health rating, there are worries on its profitability.
Over the last trailing twelve months TIVC reported a non-GAAP Earnings per Share(EPS) of -19.68. The EPS increased by 88.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -201.46% | ||
ROE | -223.08% | ||
Debt/Equity | 0 |